Health Care
Procter & Gamble's High Hopes for Joint Venture
The following commentary comes from an independent investor or market observer as part of TheStreet's guest contributor program, which is separate from the company's news coverage.
NEW YORK (Trefis) -- Procter & Gamble(PG) recently concluded the deal with Teva Pharmaceuticals(TEVA) to form a consumer health care joint venture, PGT Healthcare, after receiving approval from anti-trust authorities. Procter & Gamble, which is seeking double-digit growth opportunity in the OCT drugs business, competes with Unilever(UL), Kimberly-Clark(KMB) and Colgate-Palmolive(CL) in the beauty, personal care and consumer goods category. It also will compete with Johnson & Johnson(JNJ) in the OTC segment. See our complete analysis for Procter & Gamble's stock here. PGT Healthcare, which will focus on developing and selling branded over-the-counter (OTC) medicines, was first announced in March 2011 and recently received approval from anti-trust regulators in North America and Europe. In addition to operating in markets outside of North America to develop branded OTC drugs, it will also develop new brands for the North American market. PGT Healthcare will kick off with $1.3 billion in annual sales from the companies' existing products and expects to achieve double-digit annual growth rates to reach $4 billion in sales by 2020, by expanding into new markets and product categories. For more, read here. In its most recent quarterly report, P&G said it continues to face significant downward pressure on its gross margins because of higher input commodity inflation that is weighing over pricing measures. Yet, it maintained or improved market share in majority of its product categories. Read here for more.more here. We have Procter & Gamble with a $71.56 Trefis price estimate of its stock , (link: https://www.trefis.com/company?hm=PG.trefis), almost a 10% premium to its current market price. Click here to find out how a company's products impact its stock price at Trefis Like our charts? Embed them in your own posts using the Trefis Wordpress Plugin.TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn MoreOptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn MoreReal Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn MoreStocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn MoreTo begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,454.83 | 1,317.82 | 2,837.53 | 17.45 |
Oil *
107.26
|
|
DOWN
74.92 |
DOWN
2.86 |
DOWN
1.85 |
DOWN
0.14 |
10 Yr
1.74%
SPDR Gold
152.68
|
|
-0.60%
|
-0.22%
|
-0.07%
|
-0.80%
|
Data delayed 20 minutes |


Connect with TheStreet